639 related articles for article (PubMed ID: 3180062)
1. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors.
Perrot-Applanat M; Groyer-Picard MT; Lorenzo F; Jolivet A; Vu Hai MT; Pallud C; Spyratos F; Milgrom E
Cancer Res; 1987 May; 47(10):2652-61. PubMed ID: 2436753
[TBL] [Abstract][Full Text] [Related]
3. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical staining of progesterone receptor in paraffin sections of human breast cancers.
Perrot-Applanat M; Groyer-Picard MT; Vu Hai MT; Pallud C; Spyratos F; Milgrom E
Am J Pathol; 1989 Sep; 135(3):457-68. PubMed ID: 2675623
[TBL] [Abstract][Full Text] [Related]
5. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
Reiner GC; Katzenellenbogen BS
Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
[TBL] [Abstract][Full Text] [Related]
6. Localization of progesterone receptor with monoclonal antibodies to the human progestin receptor.
Press MF; Greene GL
Endocrinology; 1988 Mar; 122(3):1165-75. PubMed ID: 3342750
[TBL] [Abstract][Full Text] [Related]
7. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
8. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
[TBL] [Abstract][Full Text] [Related]
9. Steroid receptor analyses of nine human breast cancer cell lines.
Horwitz KB; Zava DT; Thilagar AK; Jensen EM; McGuire WL
Cancer Res; 1978 Aug; 38(8):2434-7. PubMed ID: 667841
[TBL] [Abstract][Full Text] [Related]
10. Search for estrogen receptors in human meningioma tissue sections with a monoclonal antibody against the human estrogen receptor.
Blankenstein MA; Berns PM; Blaauw G; Mulder E; Thijssen JH
Cancer Res; 1986 Aug; 46(8 Suppl):4268s-4270s. PubMed ID: 3731090
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: analysis of breast cancer cell mixtures and genetic instability of the T47D line.
Graham ML; Dalquist KE; Horwitz KB
Cancer Res; 1989 Jul; 49(14):3943-9. PubMed ID: 2660983
[TBL] [Abstract][Full Text] [Related]
12. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.
Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR
Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410
[TBL] [Abstract][Full Text] [Related]
13. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
[TBL] [Abstract][Full Text] [Related]
14. The use of fine needle aspirates in the evaluation of progesterone receptor content in breast cancer.
Lozowski M; Greene GL; Sadri D; Stanick D; Pai P; Harris MA; Lundy J
Acta Cytol; 1990; 34(1):27-30. PubMed ID: 2404374
[TBL] [Abstract][Full Text] [Related]
15. Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium.
King RJ; Coffer AI; Gilbert J; Lewis K; Nash R; Millis R; Raju S; Taylor RW
Cancer Res; 1985 Nov; 45(11 Pt 2):5728-33. PubMed ID: 2413995
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: characterization of an assay in breast cancer cell lines.
Graham ML; Bunn PA; Jewett PB; Gonzalez-Aller C; Horwitz KB
Cancer Res; 1989 Jul; 49(14):3934-42. PubMed ID: 2736533
[TBL] [Abstract][Full Text] [Related]
17. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors.
King WJ; DeSombre ER; Jensen EV; Greene GL
Cancer Res; 1985 Jan; 45(1):293-304. PubMed ID: 3965140
[TBL] [Abstract][Full Text] [Related]
18. Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand.
Press MF; Xu SH; Wang JD; Greene GL
Am J Pathol; 1989 Nov; 135(5):857-64. PubMed ID: 2683797
[TBL] [Abstract][Full Text] [Related]
19. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
[TBL] [Abstract][Full Text] [Related]
20. Relationship of monoclonal antibody binding to estrogen and progesterone receptor content in breast cancer.
Hendler FJ; Yuan D
Cancer Res; 1985 Jan; 45(1):421-9. PubMed ID: 3965148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
